Funds holding Eloxx Pharmaceuticals Inc
ISIN US29014R3012 · United States · LEI 549300UB28QGWJMFFA11
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 1.1M $
- Share of capital
- 1.9 % of 4M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 57,476 | 797.8K $ | 1.42 % | as of Jun 30, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 19,291 | 267.8K $ | 0.00 % | 0.48 % | as of Jun 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 1,036 | 14.4K $ | 0.03 % | as of Jun 30, 2026 ↗ | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 877 | 12.2K $ | 0.02 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Declared shareholders of Eloxx Pharmaceuticals Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Nantahala Capital Management, LLC and 2 others | 9.91 % | 400,000 | as of Jun 30, 2026 · SCHEDULE 13G |
| Samsara BioCapital, L.P. and 4 others | 9.90 % | 403,586 | as of Jun 10, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Eloxx Pharmaceuticals Inc". https://titelia.com/en/stocks/eloxx-pharmaceuticals-inc-US29014R3012